MicroRNA-21 as a potential colon and rectal cancer biomarker

World Journal of Gastroenterology

Volumn 19, Issue 34, 2013, Pages 5615-5621

  Li, Tao ^a   Leong, Mei Ha ^a   Harms, Bruce ^b   Kennedy, Gregory ^b   Chen, Lin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b University of Wisconsin Health   (United States)

Author keywords

Chemotherapy; Colorectal cancer; Diagnosis; MicroRNA; Treatment

Indexed keywords

FLUOROURACIL; MICRORNA; MICRORNA 106A; MICRORNA 10A; MICRORNA 125B; MICRORNA 135B; MICRORNA 137; MICRORNA 145; MICRORNA 17 3P; MICRORNA 181B; MICRORNA 191; MICRORNA 19A; MICRORNA 200C; MICRORNA 203; MICRORNA 20A; MICRORNA 21; MICRORNA 212; MICRORNA 221; MICRORNA 31; MICRORNA 320; MICRORNA 339; MICRORNA 361; MICRORNA 498; MICRORNA 92; MICRORNA 96; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

CHEMOTHERAPY; COLORECTAL CANCER; DIAGNOSIS; MICRORNA; TREATMENT;

CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883856720     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i34.5615     Document Type: Review

References (64)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300 [PMID: 20610543 DOI:10.3322/caac.20073]
2. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-894[PMID: 11521792]
3. Aslam MI, Taylor K, Pringle JH, Jameson JS. MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009; 96: 702-710[PMID: 19526617 DOI: 10.1002/bjs.6628]
4. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta 2010; 411: 1181-1186[PMID: 20452339 DOI: 10.1016/j.cca.2010]
5. Rajewsky N. MicroRNA target predictions in animals. Nat Genet 2006; 38 Suppl: S8-13[PMID: 16736023]
6. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. Mi-croRNA expression and function in cancer. Trends Mol Med 2006; 12: 580-587[PMID: 17071139]
7. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60: 167-179[PMID: 19630570 DOI: 10.1146/annurev.med]
8. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11: 228-234[PMID: 19255566 DOI: 10.1038/ncb0309-228]
9. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008; 105: 13556-13561[PMID: 18768788 DOI: 10.1073/pnas.0803055105]
10. Hagan JP, Croce CM. MicroRNAs in carcinogenesis. Cyto-genet Genome Res 2007; 118: 252-259[PMID: 18000378]
11. Peacock O, Lee AC, Larvin M, Tufarelli C, Lund JN. Mi-croRNAs: relevant tools for a colorectal surgeon? World J Surg 2012; 36: 1881-1892[PMID: 22526047 DOI: 10.1007/ s00268-012-1603-3]
12. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanai-hara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defnes cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261[PMID: 16461460]
13. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Sjob-lom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687-3692[PMID: 16505370]
14. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J, Korn-mann M, Ju J. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2006; 2: 113-121[PMID: 18079988]
15. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472-15477[PMID: 17875987]
16. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-ki-nase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008; 47: 939-946[PMID: 18663744 DOI: 10.1002/gcc.20596]
17. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-891[PMID: 14573789]
18. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A, Fritz BR, Markowitz SD, Tewari M. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008; 27: 3880-3888[PMID: 18264139 DOI: 10.1038/onc.2008.10]
19. Okayama H, Schetter AJ, Harris CC. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis 2012; 30 Suppl 2: 9-15[PMID: 23207927 DOI: 10.1159/000341882]
20. Faber C, Kirchner T, Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch 2009; 454: 359-367[PMID: 19288129 DOI: 10.1007/s00428-009-0751-9]
21. Tang JT, Fang JY. MicroRNA regulatory network in human colorectal cancer. Mini Rev Med Chem 2009; 9: 921-926[PMID: 19601887]
22. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Iden-tifcation of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858[PMID: 11679670]
23. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966[PMID: 15525708]
24. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-6033[PMID: 16024602]
25. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Ber-sani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006; 24: 4677-4684[PMID: 16966691]
26. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Col-burn NH, Post S, Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-2136[PMID: 17968323]
27. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin GR, Ewing S, Geller S, Kasimian D. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-379[PMID: 2403953]
28. Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology 2010; 138: 2044-2058[PMID: 20420945 DOI: 10.1053/ j.gastro.2010.01.054]
29. Nana-Sinkam SP, Fabbri M, Croce CM. MicroRNAs in cancer: personalizing diagnosis and therapy. Ann N Y Acad Sci 2010; 1210: 25-33[PMID: 20973796 DOI: 10.1111/ j.1749-6632.2010.05822.x]
30. Hogan NM, Joyce MR, Kerin MJ. MicroRNA expression in colorectal cancer. Cancer Biomark 2012; 11: 239-243[PMID: 23248181 DOI: 10.3233/CBM-2012-00278]
31. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haragu-chi T, Ozaki Y, Fujita S, Mizutani T, Furukawa C, Fujishiro M, Ichinose M, Shiogama K, Tsutsumi Y, Omata M, Iba H. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 2009; 15: 4009-4016[PMID: 19509156 DOI: 10.1158/1078-0432.CCR-08-3257]
32. Geiger TM, Ricciardi R. Screening options and recommendations for colorectal cancer. Clin Colon Rectal Surg 2009; 22: 209-217[PMID: 21037811 DOI: 10.1055/s-0029-1242460]
33. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shi-ratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-428[PMID: 16083699]
34. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714[PMID: 15616205]
35. Kim HJ, Yu MH, Kim H, Byun J, Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008; 41: 685-692[PMID: 18959813]
36. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S,Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23[PMID: 8978337]
37. Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Ko-pecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, Zfass A, Wright AR, Iyer RB, Lynch P, Sivak MV, Butler H. Computed tomographic colonography (virtual colonos-copy): a multicenter comparison with standard colonos-copy for detection of colorectal neoplasia. JAMA 2004; 291: 1713-1719[PMID: 15082698]
38. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381[PMID: 19201770 DOI: 10.1136/gut.2008.167817]
39. Schee K, Fodstad Ø, Flatmark K. MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 2010; 177: 1592-1599[PMID: 20829435 DOI: 10.2353/ajpath.2010.100024]
40. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet 2010; 375: 1030-1047[PMID: 20304247 DOI: 10.1016/ S0140-6736(10)60353-4]
41. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24: 5313-5327[PMID: 17060676]
42. Bedeir A, Krasinskas AM. Molecular diagnostics of colorec-tal cancer. Arch Pathol Lab Med 2011; 135: 578-587[PMID: 21526956 DOI: 10.1043/2010-0613-RAIR.1]
43. Nugent M, Miller N, Kerin MJ. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel bio-markers. Eur J Surg Oncol 2011; 37: 649-654[PMID: 21632200 DOI: 10.1016/j.ejso.2011.05.005]
44. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18: 350-359[PMID: 18270520 DOI: 10.1038/ cr.2008.24]
45. Slaby O, Svoboda M, Fabian P, Smerdova T, Knofickova D, Bednarikova M, Nenutil R, Vyzula R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinico-pathologic features of colorectal cancer. Oncology 2007; 72: 397-402[PMID: 18196926 DOI: 10.1159/000113489]
46. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-436[PMID: 18230780 DOI: 10.1001/jama.299.4.425]
47. Nielsen BS, Jørgensen S, Fog JU, Søkilde R, Christensen IJ, Hansen U, Brünner N, Baker A, Møller S, Nielsen HJ. High levels of MicroRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011; 28: 27-38[PMID: 21069438 DOI: 10.1007/s10585-010-9355-7]
48. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology 2008; 134: 1296-1310 [PMID: 18471507 DOI: 10.1053/j.gastro.2008.02.098]
49. Simunovic M, Smith AJ, Heald RJ. Rectal cancer surgery and regional lymph nodes. J Surg Oncol 2009; 99: 256-259[PMID: 19101955 DOI: 10.1002/jso.21217]
50. Urso ED, Nascimbeni R, Pucciarelli S, Agostini M, Casella C, Moneghini D, Di Lorenzo D, Maretto I, Sullivan M, Mammi I, Viel A, Nitti D. Factors affecting the treatment of multiple colorectal adenomas. Surg Endosc 2013; 27: 207-213[PMID: 22773231 DOI: 10.1007/s00464-012-2421-2]
51. Rossi L, Bonmassar E, Faraoni I. Modifcation of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 2007; 56:248-253[PMID: 17702597]
52. Tomimaru Y, Eguchi H, Nagano H, Wada H, Tomokuni A, Kobayashi S, Marubashi S, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepa-tocellular carcinoma cells. Br J Cancer 2010; 103: 1617-1626[PMID: 20978511 DOI: 10.1038/sj.bjc.6605958]
53. Svoboda M, Izakovicova Holla L, Sefr R, Vrtkova I, Koca-kova I, Tichy B, Dvorak J. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. Int J Oncol 2008; 33: 541-547[PMID: 18695884]
54. Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li CH, Leung GK. MicroRNA-21 inhibition enhances in vitro chemosensi-tivity of temozolomide-resistant glioblastoma cells. Anticancer Res 2012; 32: 2835-2841[PMID: 22753745]
55. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-medi-ated tumor growth. Oncogene 2007; 26: 2799-2803[PMID: 17072344]
56. Zhu H, Luo H, Li Y, Zhou Y, Jiang Y, Chai J, Xiao X, You Y, Zuo X. MicroRNA-21 in Scleroderma Fibrosis and its Function in TGF-β- Regulated Fibrosis-Related Genes Expression. J Clin Immunol 2013; 33: 1100-1109[PMID: 23657402]
57. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008; 28: 5369-5380[PMID: 18591254 DOI: 10.1128/MCB.00479-08]
58. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689[PMID: 16258535]
59. Wang V, Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009; 23: 15-23[PMID: 19344188 DOI: 10.2165/0006 3030-200923010-00002]
60. Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011; 17: 5231-5239[PMID: 22219591 DOI: 10.3748/wjg.v17. i48.5231]
61. Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, Banner BF, Chen YT. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 2009; 33: 572-582[PMID: 19047896 DOI: 10.1097/ PAS.0b013e31818afd6b]
62. Link A, Balaguer F, Shen Y, Nagasaka T, Lozano JJ, Boland CR, Goel A. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 2010; 19: 1766-1774[PMID: 20551304 DOI: 10.1158/1055-9965. EPI-10-0027]
63. Chang KH, Miller N, Kheirelseid EA, Lemetre C, Ball GR, Smith MJ, Regan M, McAnena OJ, Kerin MJ. MicroRNA signature analysis in colorectal cancer: identifcation of expression profles in stage II tumors associated with aggressive disease. Int J Colorectal Dis 2011; 26: 1415-1422[PMID: 21739196 DOI: 10.1007/s00384-011-1279-4]
64. Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L, Cerny R. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 2010; 200: 154-160[PMID: 20620599 DOI: 10.1016/j.cancergencyto.2010.04.015]